James Haridy

5PUBLICATIONS
18CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursGene and molecular therapyNatural language processing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 27, 2024
Prostate-Specific Membrane Antigen (PSMA) PET/CT in the Detection and Diagnosis of Hepatocellular Carcinoma (HCC): A Systematic Review and Meta-Analysis.

Nicholas Hannah, Catherine Yu, Leya Nedumannil

|Sep 14, 2024
Initial Trans-Arterial Chemo-Embolisation (TACE) Is Associated with Similar Survival Outcomes as Compared to Upfront Percutaneous Ablation Allowing for Follow-Up Treatment in Those with Single Hepatocellular Carcinoma (HCC) ≤ 3 cm: Results of a Real-World Propensity-Matched Multi-Centre Australian Cohort Study.

Jonathan Abdelmalak, Simone I Strasser, Natalie L Ngu

|Jun 19, 2024
Different Patterns of Care and Survival Outcomes in Transplant-Centre Managed Patients with Early-Stage HCC: Real-World Data from an Australian Multi-Centre Cohort Study.

Jonathan Abdelmalak, Simone I Strasser, Natalie L Ngu

|Sep 06, 2020
Outcomes of community-based hepatitis C treatment by general practitioners and nurses in Australia through remote specialist consultation.

James Haridy, Guru Iyngkaran, Amanda Nicoll

|Jun 12, 2018
Real-world outcomes of unrestricted direct-acting antiviral treatment for hepatitis C in Australia: The South Australian statewide experience.

J Haridy, A Wigg, K Muller

Pageof 1

Frequent Collaborators

2 joint publications

John Zalcberg

2 joint publications

Jonathan Abdelmalak

2 joint publications

Simone I Strasser

2 joint publications

Marie Sinclair